Kedudukan dalam Saham
#39900
Abpro Holdings, Inc. is a biotechnology firm dedicated to creating... Abpro Holdings, Inc. is a biotechnology firm dedicated to creating antibody-based treatments for patients suffering from conditions in immuno-oncology, ophthalmology, and autoimmunity. A key element of their strategy is the proprietary DiversImmune platform, which aims to resolve a significant hurdle in the antibody therapeutics sector. Their primary investigational drug candidates include ABP-100, designed to target breast, gastric, and colorectal cancers, and ABP-201, intended for the treatment of vascular diseases affecting the eye. The company has established strategic alliances with Abpro Bio Co. Ltd and NJCTTQ. Originally known as Abpro Corporation, the company officially changed its name to Abpro Holdings, Inc. in November 2024. Incorporated in 2004, Abpro Holdings, Inc. operates from its headquarters in Woburn, Massachusetts.
Harga Saham
$0.158
Disegerakkan terakhir: 2026-04-06
Perubahan (1 hari)
16.18%
Perubahan (1 tahun)
-97.91%
Perdagangan Abpro Corporation (ABP)
Harga ABP dengan permodalan pasaran b
Modal pasaran bagi Abpro Corporation(ABP)
Modal Pasaran: $302.92K
Sehingga August 2026, Abpro Corporation mempunyai modal pasaran sebanyak $302.92K. Ini menjadikan Abpro Corporation syarikat ke-39900th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Abpro Corporation dari 2024 hingga 2026
ABP berbanding dengan 5 teratas yang paling popular stocks
| Harga ABP |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.470T
|
+1,805,575,590.80%
|
|
|
|
|
$4.467T
|
+1,474,646,479.12%
|
|
|
|
|
$4.174T
|
+1,378,026,865.56%
|
|
|
|
|
$3.700T
|
+1,221,450,398.25%
|
|
|
|
|
$2.854T
|
+942,260,836.96%
|
